Review decisions
Showing 570 results of 1550 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01084
Product Type: Drug
Control Number: 249774
DIN(s): 02526794, 02526808, 02526816, 02526824
Manufacturer: Allergan Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2021-02-22
Decision / Authorization Date: 2022-04-22
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01003
Product Type: Drug
Control Number: 255136
DIN(s): 02526670
Manufacturer: Vertex Pharmaceuticals Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-07-27
Decision / Authorization Date: 2022-04-20
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00939
Product Type: Drug
Control Number: 258295
DIN(s): 02526271
Manufacturer: AstraZeneca Canada Inc.
Submission Type: New Drug Submission (New Active Substance) (COVID-19)
Date Filed / Submission Date: 2021-11-03
Decision / Authorization Date: 2022-04-14
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00996
Product Type: Drug
Control Number: 248255
DIN(s): 02526662
Manufacturer: Vifor Fresenius Medical Care Renal Pharma Ltd.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2021-04-12
Decision / Authorization Date: 2022-04-14
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00945
Product Type: Drug
Control Number: 256659
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission - Priority Review
Date Filed / Submission Date: 2021-09-15
Decision / Authorization Date: 2022-04-12
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00997
Product Type: Drug
Control Number: 248992
Manufacturer: Celgene Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-01-29
Decision / Authorization Date: 2022-04-08
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01066
Product Type: Drug
Control Number: 252068
DIN(s): 02526441
Manufacturer: BGP Pharma ULC
Submission Type: New Drug Submission
Date Filed / Submission Date: 2021-04-26
Decision / Authorization Date: 2022-04-08
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00944
Product Type: Drug
Control Number: 257236
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-03-01
Decision / Authorization Date: 2022-04-07
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00938
Product Type: Drug
Control Number: 251509
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-04-07
Decision / Authorization Date: 2022-04-06
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01039
Product Type: Drug
Control Number: 256491
Manufacturer: Boehringer Ingelheim Canada Ltd./Ltée.
Submission Type: Supplement to a New Drug Submission - Priority Review
Date Filed / Submission Date: 2021-09-09
Decision / Authorization Date: 2022-04-06